Comparing OSSIX4 Breeze and Jason4 Membranes for Ridge Augmentation in Patients Getting Dental Implants

What this Trial Is About

Researchers are conducting a prospective randomized controlled trial to evaluate bone formation and soft tissue healing in patients with ridge deficiencies undergoing simultaneous dental implantation. The study compares two types of pericardium membranes a sugar cross-linked membrane called OSSIX Breeze and a native pericardium membrane called Jason. The goal is to assess differences in bone gain and soft tissue healing at 4 and 8 months after treatment. Participants will receive one of the two barrier membranes during their guided bone regeneration treatment for ridge augmentation. Eligible adults needing 1 to 3 dental implants and having buccal bone defects will be randomly assigned to either the OSSIX Breeze membrane group or the Jason membrane group. The trial involves close follow-up to evaluate healing outcomes at specified time points. During the study, participants will be monitored for bone gain at 4 months as the primary outcome measure. Researchers will assess oral hygiene, inflammation control, and overall healing progress through follow-up examinations. Participants are expected to maintain good oral hygiene and attend all scheduled visits. The study is sponsored by Datum Dental LTD and aims to provide clear information on the comparative performance of these two membranes in ridge augmentation procedures.

Ridge Augmentation Treatment Using OSSIX® BREEZE vs Jason®